Suiyan Weng on Muck Rack

Suiyan Weng

As seen in: Frontiers in Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Suiyan

Contact Suiyan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Frontiers | Glypican 3-targeted chimeric antigen receptor T cells secreting TROP2-directed bispecific T cell engagers exhibit potent efficacy against lung squamous cell carcinoma

|
By Liming Lin, Haiqing Zhang, Suiyan Weng, Lianjie Ruan, Dekai Lin, Mengqing Lin
| Frontiers in Immunology
1 Introduction Lung Squamous cell carcinoma (LUSC) is a major subtype of lung cancer and belongs to non-small cell lung cancer (NSCLC). It originates from the squamous epithelial cells of the lung and is characterized by keratinized regions and intercellular bridges. Usually occurring in the central part of the lung, it is closely related to smoking (1, 2). LUSC is the second most common subtype of NSCLC, accounting for approximately 25-30% of NSCLC cases (3).
Open in Who Shared Issue with article?
See all 1 licensed articles (2 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified